Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Urology Oncology is Scopus-indexed (Q1, CiteScore 10.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2588-9311Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$3,790 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 6 / 597 | 99th | Q1 |
| Radiology, Nuclear Medicine and Imaging | 16 / 361 | 95th | Q1 |
| Urology | 6 / 123 | 95th | Q1 |
| Oncology | 48 / 428 | 88th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q1, CiteScore 10.7.
European Urology Oncology is Q1 in Surgery (rank 6 of 597), Q1 in Radiology, Nuclear Medicine and Imaging (rank 16 of 361) and Q1 in Urology (rank 6 of 123), by CiteScore 2025. It is ranked in 4 subject areas in all.
European Urology Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.7, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.010, quartile Q1, with an H-index of 63.
The publisher lists an article processing charge of about US$3,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
European Urology Oncology is published by Elsevier B.V. Its ISSN is 2588-9311.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
European Urology Oncology has an h-index of 78 and a 2-year mean of 5.05 citations per paper (OpenAlex). Its Scopus CiteScore is 10.7, quartile Q1. On 2-year citations it ranks #10 of 585 Scopus journals in Surgery.
European Urology Oncology published 226 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from United States (24.5%), France (13%) and Italy (12.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.